医学
鲁索利替尼
免疫学
骨髓增生异常综合症
耐火材料(行星科学)
银屑病
炎症
全血细胞减少症
内科学
泼尼松龙
种系突变
白细胞减少症
复发性多软骨炎
贫血
来那度胺
骨髓衰竭
皮肤病科
阿扎胞苷
肿瘤科
体细胞
疾病
头痛
大细胞贫血
英夫利昔单抗
银屑病性关节炎
全身性疾病
作者
Mohamed M. Khamis,Iqra Bhatti,Deepthi Busayavalasa
出处
期刊:Case Reports
[BMJ]
日期:2026-05-01
卷期号:19 (5): e271503-e271503
标识
DOI:10.1136/bcr-2025-271503
摘要
A man in his early 80s presented with transfusion-dependent macrocytic anaemia, steroid-responsive headaches and recurrent inflammatory flares. Broad infectious, autoimmune and haematological investigations were negative, yet symptoms relapsed each time prednisolone was tapered. The coexistence of refractory inflammation, giant cell arteritis-like features and progressive cytopenias prompted targeted sequencing, which uncovered a somatic UBA1 p.Met41Thr mutation and confirmed vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. Empirical antimicrobials and high-dose steroids provided only brief control. Ruxolitinib followed by subcutaneous azacitidine stabilised inflammatory markers, enabled gradual steroid tapering and reduced hospitalisations although anaemia remained. This case highlights key diagnostic and management principles. First, clinicians should consider VEXAS in older men with overlapping vasculitic and myelodysplastic features. Second, molecular testing should be pursued even when marrow vacuoles are subtle. Thirdly, multidisciplinary care combining steroid-sparing immunomodulators with clonal-directed therapy is essential.
科研通智能强力驱动
Strongly Powered by AbleSci AI